Get started
Author

Yara Shatnawi

ORCID: 0009-0001-9068-5474
Observed ORCID: 0009-0001-9068-5474
OpenAlex ID: A5093394269
Global Access to Multiple Myeloma Therapies
2025 · Rawan Atallah, Yara Shatnawi, et al. · JCO Global Oncology · 6
The GLAMM1 Study - Global Access to Myeloma Medications: Potential Barriers to Chimeric Antigen Receptors (CART) and T-Cell-Engaging Bispecific Antibodies (TCE) Globally
2023 · Rawan Atallah, Yara Shatnawi, et al. · Blood · 4
Management of relapsed refractory multiple myeloma: Evidence-based guide to community oncologists
2025 · Ali Mushtaq, Asfand Yar Cheema, et al. · Blood Reviews · 3
The GLAMM1 Study - Global Access to Myeloma Medications: Potential Barriers to Chimeric Antigen Receptors (CART) and T-Cell-Engaging Bispecific Antibodies (TCE) Globally
2024 · Rawan Atallah, Yara Shatnawi, et al. · Transplantation and Cellular Therapy · 3
Real-World Practice in the Management of Transplant-Eligible Newly Diagnosed Multiple Myeloma: A US-Based Cross-Sectional National Survey
2025 · Hossam M. Ali, Zainab Yusufali Motiwala, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Title: Achieving Minimal Residual Disease (MRD) Negativity during the Disease Course in relapsed/refractory Multiple Myeloma (RRMM): Implications for Treatment and Transplant Strategies
2026 · Ali Awada, Amjad Alguraan, et al. · Transplantation and Cellular Therapy
Sustained Minimal Residual Disease (MRD) Negativity for ≥1 Year in Transplant Eligible Newly Diagnosed Multiple Myeloma (NDMM): A Systematic Review of Prospective Clinical Trials
2026 · Ali Awada, Amjad Alguraan, et al. · Transplantation and Cellular Therapy
Outcomes of pPCL Diagnosed Using the IMWG 2021 Consensus Definition: A Retrospective Multicenter Analysis
2026 · Priyanka Venkatesh, Razan Mansour, et al. · Cancers
PDF
S509 Clinical Characteristics of Patients With Colonic Oligopolyposis of Unknown Etiology: A Single-Center Experience
2025 · Islam Mohamed, Ahmed N. Mohamed, et al. · The American Journal of Gastroenterology
S367 Neighborhood Socioeconomic Disadvantage (Area Deprivation Index) and Genetic Counseling Attendance in Patients Referred for Genetic Testing for Colorectal Adenomatous Oligopolyposis: A Real-World Retrospective Study
2025 · Ahmed N. Mohamed, Moath Albliwi, et al. · The American Journal of Gastroenterology
S302 Factors Associated With Referral for Genetic Counseling in Patients With 10-99 Cumulative Colorectal Adenomas: A Single Center Retrospective Study
2025 · Ahmed N. Mohamed, Moath Albliwi, et al. · The American Journal of Gastroenterology
Works count: 11
Citation count: 17
H-index: 3
I10-index:
Year
Topic
Type